The following news items are related to the research Urological cancers.
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.
RIMLS 25 years jubilee festival The Future is Yesterday3 October 2019
Together with more than 250 colleagues and alumni we celebrated 25 years of research into the molecular mechanisms of disease. During this exciting and informal event, we not only took a trip down memory lane, but also looked ahead to the next 25 years and beyond…...
Cost-effectiveness of mpMRI in active surveillance of prostate cancer25 June 2019
In European Urology Oncology Sejal Patel and colleagues evaluated the potential cost-effectiveness of including mpMRI in active surveillance for men diagnosed with low-risk prostate cancer in comparison to the standard monitoring program.
Intake of a reduced dose of pazopanib with food the effect on pharmacokinetics, patient safety and preference13 June 2019
In Clinical Pharmacology & Therapeutics Floor Lubberman and colleagues showed that the intake of 600mg pazopanib with food resulted in a bioequivalent exposure and was preferred over a standard pazopanib dose without food.
How do we keep new technology affordable to improve the lives of people?16 May 2019
Improving healthcare by means of new technological developments? We need to change the entire approach for evaluating the true impact , says Maroeska Rovers. By bringing together all stakeholders from the beginning, millions of euros can be saved.
Algorithm calculates the presence and aggressiveness of prostate tumors14 May 2019
A computer program that analyzes MRI images can reliably map the presence and even the aggressiveness of a prostate tumor. This is what Radboudumc researchers and international colleagues have published in the scientific journal Investigative Radiology.
A new therapeutic option for the treatment of castration-resistant prostate cancer5 February 2019
Jack Schalken and Vicky Luna Velez and colleagues, theme Urological cancers, published in Oncogene about suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis.
Julia van Tol-Geerdink appointed member Dutch Health Council31 January 2019
Julia van Tol-Geerdink is appointed as member of the Dutch Health Council (Gezondheidsraad). She is now member of the permanent committee on Population screening and of the temporary committee on AAA screening (Abdominal Aorta Aneurysm).
MRI improves detection of prostate cancer Prostate biopsy no longer necessary for 50% of male patients4 December 2018
There is good news for the more than 40,000 men per year who go to the hospital for diagnosis because of elevated Prostate-Specific Antigen (PSA) levels. “Thanks to the use of MRI, we can reduce the number of prostate biopsies by half,” says Jelle Barentsz.
Active surveillance in the majority of Dutch patients with very low risk prostate cancer27 November 2018
In Prostate Cancer and Prostatic Diseases Katja Aben and colleagues showed that most Dutch patients with very low risk prostate cancer are managed with active surveillance, thereby delaying and possible avoiding therapy and its side effects.
Report of the 12th New Frontiers symposium Big data, better healthcare? - 1 November 20187 November 2018
Examples from the application of deep learning to image reading in pathology and radiology and the application of network medicine to monitor infectious disease outbreaks or collective mood states using twitter data showed the huge potential of big data approaches for building better healthcare.
Report of the 12th New Frontiers symposium Better care, network care? - 2 November 20187 November 2018
No easy answers at this symposium last Friday, only challenges that can be overcome if we succeed in 5 things. First and most radically, put patients in the center of healthcare. Second, start with assessing what the local population needs and not what local professionals have to offer.
A personal touch of Anglita Yanti Setiasti12 July 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Anglita Yanti Setiasti
Operating theaters in Radboud university medical center optimally equipped to collaborate with industry ERDF grant for Radboud university medical center, Demcon, Encapson and NewCompliance16 March 2018
The European Regional Development Fund has awarded funding worth almost € 600,000 to Radboud university medical center, Demcon, Encapson and NewCompliance to enable the develop and test of new products in operating theaters.
Organize an international symposium? Be involved in the ENABLE 2019 Nijmegen event15 March 2018
For the organisation of ENABLE 2019, we are searching for a Local Organising Committee (LOC). PhD candidates and postdocs who would like to be involved in hosting the European young researcher symposium in Nijmegen 2019.
Save the date for Radboud New Frontiers 2018: Betere zorg, netwerkzorg?17 January 2018
After standard care, standardized care, and personalized care, network care will be care 4.0. But how exactly do you do that? Should we create new structures for it or is it just a matter of trust and ability to step back?
Save the date for Radboud New Frontiers 2018: Big data, better healthcare?17 January 2018
How is big data influencing healthcare and healthcare research? How will it help us and what are the limitations? The first day of the 12th edition of the Radboud New Frontiers symposium, on 1 November 2018, will give you all the answers (and raises new questions).